Trial Profile
A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2014
Price :
$35
*
At a glance
- Drugs Enclomifene (Primary)
- Indications Hypogonadism; Male infertility; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Repros Therapeutics
- 13 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Apr 2014 New trial record